ConductScience.org, home

Paper26314532

Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention.

Généreux P and 18 others. J Am Coll Cardiol, 2015. Cited by 386 papers, by iCite.

Cite this record

ConductScience Library. Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention. Papers, record 26314532. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26314532

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention.
PubMed
Journal
J Am Coll Cardiol
PubMed
Year
2015
PubMed
Publication types
Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial
PubMed
Citations, by iCite
386
iCite
Relative citation ratio, by iCite
12.6
iCite
Revised in PubMed
2022-04-09
PubMed

Authors19

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Généreux PPhilippe
2Giustino GGennaro
3Witzenbichler BBernhard
4Weisz GGiora
5Stuckey TDThomas D
6Rinaldi MJMichael J
7Neumann FJFranz-Josef
8Metzger DCD Christopher
9Henry TDTimothy D
10Cox DADavid A
11Duffy PLPeter L
12Mazzaferri EErnest
13Yadav MMayank
14Francese DPDominic P
15Palmerini TTullio
16Kirtane AJAjay J
17Litherland CClaire
18Mehran RRoxana
19Stone GWGregg W

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Coronary Artery DiseaseMajor topic
Drug-Eluting StentsMajor topic
Percutaneous Coronary InterventionMajor topic
Platelet Aggregation InhibitorsMajor topic
Postoperative HemorrhageMajor topic
Adult
Aged
Dose-Response Relationship, Drug
Drug Administration Schedule
Follow-Up Studies
Humans
Middle Aged
Multivariate Analysis
Patient Discharge
Platelet Aggregation
Postoperative Care
Predictive Value of Tests
Proportional Hazards Models
Prospective Studies
Radiography
Risk Assessment
Survival Analysis
Treatment Outcome

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT00638794Assessment of Dual AntiPlatelet Therapy With Drug Eluting StentsDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in26314533The Shifting Pendulum for DAPT After PCI: Balancing Long-Term Risks for Bleeding and Thrombosis.https://conductscience.org/library/papers/26314533

Source PubMed

Download CSV of comments and corrections

Cited by162

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 386 citations.

PMIDTitleJournalYearIn PapersSource
42911529The FIBR-CMR score: a novel risk model integrating fibrinogen and cardiac magnetic resonance for major adverse events after STEMI.Radiol Med2026https://conductscience.org/library/papers/42911529PubMed
42856937Limited Impact of High Bleeding Risk Calculation and Peri-Procedural Discussion on Dual-Antiplatelet Therapy Duration and Clinical Outcomes After Percutaneous Coronary Intervention.Circ Rep2026https://conductscience.org/library/papers/42856937PubMed
42795913Gastrointestinal Bleeding Is Associated with Worse In-Hospital Outcomes in Patients with ST-Segment Elevation Myocardial Infarction: An Analysis of the National Inpatient Sample.J Clin Med2026https://conductscience.org/library/papers/42795913PubMed
42534206Long-Term Antithrombotic Therapy After Percutaneous Coronary Intervention: Secondary Prevention Beyond One Year.Rev Cardiovasc Med2026https://conductscience.org/library/papers/42534206PubMed
42389288Association of blood-activating commercial Chinese polyherbal preparation with clinical outcomes in older patients with ischemic cardiovascular or cerebrovascular diseases: a real-world cohort study.Front Pharmacol2026https://conductscience.org/library/papers/42389288PubMed
41783931Comparison of Cardiovascular Events in Patients Receiving Concomitant Clopidogrel and Proton Pump Inhibitors Classified by CYP2C19 Inhibitory Potency.Arterioscler Thromb Vasc Biol2026https://conductscience.org/library/papers/41783931PubMed
41710573Development and External Validation of a Nomogram for Predicting Upper Gastrointestinal Bleeding in Patients After Percutaneous Coronary Intervention: A Retrospective Multicenter Cohort Study.Int J Gen Med2026https://conductscience.org/library/papers/41710573PubMed
41709119The Prognostic Impact of Multiple Adverse Events on Long-Term Mortality Following Acute Myocardial Infarction.Catheter Cardiovasc Interv2026https://conductscience.org/library/papers/41709119PubMed
41682970LOw-Dose RAbeprazole Therapy for Reducing Gastrointestinal Events in Patients with High Bleeding Risk (LORA-HBR): A Prospective, Multicenter, Interventional Study.J Clin Med2026https://conductscience.org/library/papers/41682970PubMed
41554563Clinical Outcomes of Tegoprazan Versus Proton Pump Inhibitors in Patients Receiving Antiplatelet Therapy After Percutaneous Coronary Intervention: A Retrospective, Observational Study.Korean J Helicobacter Up Gastrointest Res2026https://conductscience.org/library/papers/41554563PubMed
41509615Abbreviated dual antiplatelet therapy after percutaneous coronary intervention with ultrathin-strut drug-eluting stents in South Korea: 3-year outcomes of the multicentre, randomised HOST-IDEA trial.EClinicalMedicine2026https://conductscience.org/library/papers/41509615PubMed
41420206The impact of heart failure and bleeding risk on clinical outcomes in patients after percutaneous coronary intervention.BMC Cardiovasc Disord2025https://conductscience.org/library/papers/41420206PubMed
41307518Effect of Proton Pump Inhibitors in Patients Undergoing Percutaneous Coronary Intervention With Aspirin-Free Strategy.JACC Asia2026https://conductscience.org/library/papers/41307518PubMed
41276650Association between the modified Japanese Version of High Bleeding Risk scores and clinical outcomes in Japanese patients with lower extremity artery disease undergoing endovascular treatment.Heart Vessels2026https://conductscience.org/library/papers/41276650PubMed
41081254Associations of Thrombotic and Bleeding Risks With Plaque Morphology.Circ Rep2025https://conductscience.org/library/papers/41081254PubMed
40944090Antiplatelet Therapy in Atrial Fibrillation Patients on Direct Oral Anticoagulants Undergoing Percutaneous Coronary Intervention: Which and How.J Clin Med2025https://conductscience.org/library/papers/40944090PubMed
40808251Drug-Coated Balloon-Based Versus Drug-Eluting Stent-Only Treatment for Large Vessel Coronary Artery Disease.Catheter Cardiovasc Interv2025https://conductscience.org/library/papers/40808251PubMed
40802193Age-Stratified Effect of Rivaroxaban Monotherapy for Atrial Fibrillation in Stable Coronary Artery Disease: A Post Hoc Analysis of the AFIRE Randomized Clinical Trial.JAMA Cardiol2025https://conductscience.org/library/papers/40802193PubMed
40634660Local Infusing Antiplatelet Microspheres to Prevent Thrombosis Post-PCI: a Feasibility Study in Rabbit Aorta.Mol Imaging Biol2025https://conductscience.org/library/papers/40634660PubMed
40461183Dual impact of anaemia and chronic kidney disease on postpercutaneous coronary intervention outcomes: insights from the Japanese nationwide registry.Open Heart2025https://conductscience.org/library/papers/40461183PubMed

See all 162 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26314532

GET https://conductscience.org/api/papers/v1/26314532/cited_by?page=2